Fertility and Sterility
Volume 93, Issue 1 , Pages 268.e15-268.e18 , 1 January 2010

Gene expression during successful implantation in a natural cycle

Presented at the 25th Annual Meeting of the European Society of Human Reproduction and Embryology, Amsterdam, The Netherlands, June 28–July 1, 2009.

  • Inge Van Vaerenbergh, M.Sc.

      Affiliations

    • Department of Pathology, UZ Brussel and Vrije Universiteit Brussel, Jette, Belgium
    • Corresponding Author InformationReprint requests: Inge Van Vaerenbergh, M.Sc., Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Brussels, Belgium (FAX: =32 2 477 48 09).
    • ,
  • Ramsey McIntire, Ph.D.

      Affiliations

    • Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco (UCSF), San Francisco, California
    • ,
  • Leentje Van Lommel, M.Sc.

      Affiliations

    • Department of Molecular Cell Biology, Gene Expression Unit, KU Leuven, Leuven, Belgium
    • ,
  • Paul Devroey, M.D., Ph.D.

      Affiliations

    • Centre for Reproductive Medicine, UZ Brussel, Jette, Belgium
    • ,
  • Linda Giudice, M.D., Ph.D., M.Sc.

      Affiliations

    • Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco (UCSF), San Francisco, California
    • ,
  • Claire Bourgain, M.D., Ph.D.

      Affiliations

    • Department of Pathology, UZ Brussel and Vrije Universiteit Brussel, Jette, Belgium

Received 16 June 2009 ,Revised 16 August 2009 ,Accepted 24 August 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 I.V.V. has nothing to disclose. R.M. has nothing to disclose. L.V.L. has nothing to disclose. P.D. has received grant support from Merck, Schering Plough, Ferring, IBSA, Besins, Anecova. L.G. is a consultant for Repros Therapeutics, Quest Diagnostics, EMD Serono, Biosante, Vantia Therapeutics, and Bayer Schering Pharma; and owns stock in Pfizer. C.B. has nothing to disclose.

 Supported by grant AL405 from Research Foundation-Flanders (FWO), Belgium, and by National Institute of Child Health and Human Development/National Institutes of Health, Bethesda, MD, through a cooperative agreement U54HD055764-02 (LCG) as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research.

PII: S0015-0282(09)03596-1

doi: 10.1016/j.fertnstert.2009.08.057

Fertility and Sterility
Volume 93, Issue 1 , Pages 268.e15-268.e18 , 1 January 2010

Article Tools

* Image Usage & Resolution